FHL2 and Familial prostate cancer: This observation is correlated with recent discoveries that invasive breast cancers have much stronger expression of FHL2 than premalignant ductal carcinoma in situ samples [25] and that increases of nuclear FHL2 in prostate cancer are strongly correlated with dedifferentiation of cancer cells and with high Gleason grade [6].